Global Peptide Synthesis Market Analysis and Outlook 2024: Competitive Analysis of Leading Market Players, Product Developments, Key Financial and Segmental Revenues [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028. The key factors driving the growth of the global peptide synthesis market include rising prevalence of chronic diseases, increase in biotech spending, development in peptide drug delivery and an increase in infectious and chronic diseases. The report provides a detailed summary of the peptide synthesis market, with a focus on peptide therapeutics; a competitive landscape; and company profiles that include revenue, product portfolio and news in development. The report analyzes market trends and dynamics, including drivers, restraints and opportunities. This research study discusses historical year, base year and potential market size for the forecast period. The report will enable key players, other strategists and start-ups to make informed dec
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Amgen investors await weight-loss drug data [Yahoo! Finance]Yahoo! Finance
- Amgen investors await weight-loss drug data [Reuters]Reuters
- The Ozempic Effect: How a Weight Loss Wonder Drug Gobbled Up an Entire Economy [Yahoo! Finance Canada]Yahoo! Finance Canada
- Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes [Reuters]Reuters
- Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 11/3/23 - Beat
NVO
Sec Filings
- 5/1/24 - Form 6-K
- 4/26/24 - Form 6-K
- 4/25/24 - Form 6-K
- NVO's page on the SEC website